Doctor profile · Federal record
Dr. Matthew Mavissakalian, D.O.
Allergy & Immunology Physician (CMS: Allergy/Immunology) · Tonawanda, NY
- NPI 1790028397
- Accepts Medicare
- 13 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
2540 Sheridan Dr
Tonawanda, NY 141509410
(716) 874-8980 - Mailing address
-
2157 Main St
Buffalo, NY 142142648
Credentials & registration
- NPI registered
- April 2013 — 13 yrs on file
- Profile last updated
- November 5, 2018
- Year of graduation
- 2013 — 13 yrs since
- Specialty taxonomy
- 207K00000X — NUCC code
- State license (1)
- New York #293451
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1790028397. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
774
Distinct HCPCS
5
Medicare allowed
$10,954
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
95004 |
Test for allergy using allergenic extract | 375 | 17 | $4 | |
95024 |
Test for allergy using allergenic extract injected into skin | 220 | 16 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 64 | 54 | $85 | |
95117 |
Professional service for multiple injections of allergen | 58 | 17 | $10 | |
94060 |
Test to measure expiratory airflow and volume changes before and after medication administration | 57 | 49 | $35 |
In context: peer comparison
Among 1 peers in Tonawanda Allergy & Immunology Physician, average services per provider: 154. This provider delivers 5.0× the peer median.Open Payments
Industry payments received
All-time total
$2,302
Transactions
108
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | 32 | $481.56 | |
| Genzyme Corporation | 15 | $326.83 | |
| AstraZeneca Pharmaceuticals Lp | 10 | $317.51 | |
| GlaxoSmithKline, LLC. | 16 | $299.81 | |
| Amgen INC. | 4 | $195.34 | |
| Pfizer INC. | 7 | $136.04 | |
| Csl Behring | 4 | $105.03 | |
| Genentech USA, INC. | 5 | $94.59 | |
| BioCryst US Sales Co., LLC | 4 | $84.48 | |
| Takeda Pharmaceuticals U.S.A., INC. | 3 | $75.28 | |
| Pharming Healthcare, INC. | 3 | $69.85 | |
| Kaleo, INC. | 2 | $45.74 | |
| Octapharma USA, INC. | 1 | $22.71 | |
| Grifols USA, LLC | 1 | $18.34 | |
| Optinose US, INC. | 1 | $15.68 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
833
Patients
267
Total drug cost
$258,637
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Azelastine Hcl | Generic | 159 | 74 | $4,287 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 129 | 62 | $4,129 |
| Fluticasone Propionate | Generic | 77 | 23 | $1,048 |
| Qvar Redihaler (Beclomethasone Dipropionate) | Brand | 56 | 20 | $17,359 |
| Fluticasone-Salmeterol (Fluticasone Propion/Salmeterol) | Brand | 53 | 15 | $10,473 |
| Ipratropium Bromide | Generic | 51 | 18 | $2,175 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 45 | 0 | $30,561 |
| Levocetirizine Dihydrochloride | Generic | 40 | 0 | $1,002 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 39 | 14 | $24,301 |
| Dupixent Pen (Dupilumab) | Brand | 34 | 0 | $132,308 |
Frequently asked questions
What is Dr. Matthew Mavissakalian's medical specialty?
Dr. Matthew Mavissakalian practices Allergy & Immunology Physician in Tonawanda, NY.
Where does Dr. Matthew Mavissakalian practice?
Dr. Matthew Mavissakalian practices at 2540 Sheridan Dr, Tonawanda, NY 141509410. Office phone: 7168748980.
What is Dr. Matthew Mavissakalian's NPI?
Dr. Matthew Mavissakalian's National Provider Identifier (NPI) is 1790028397, issued by NPPES.
Does Dr. Matthew Mavissakalian accept Medicare assignment?
Yes. Dr. Matthew Mavissakalian accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Matthew Mavissakalian commonly perform?
Top Medicare-reported procedures in 2023: Test for allergy using allergenic extract (HCPCS 95004); Test for allergy using allergenic extract injected into skin (HCPCS 95024); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.